Author:
Chen Ya-Ping,Hou Xiao-Yang,Yang Chun-Sheng,Jiang Xiao-Xiao,Yang Ming,Xu Xi-Feng,Feng Shou-Xin,Liu Yan-Qun,Jiang Guan
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57(1):43–66.
2. Weinstein D, Leininger J, Hamby C, et al. Diagnostic and prognostic biomarkers in melanoma. J Clin Aesthet Dermatol. 2014;7(6):13–24.
3. Jiang G, Wei ZP, Pei DS, et al. A novel approach to overcome temozolomide resistance in glioma and melanoma: inactivation of MGMT by gene therapy. Biochem Biophys Res Commun. 2011;406(3):311–4.
4. Friedman HS, Kerby T, Calvert H. Temozolomide and treatment of malignant glioma. Clin Cancer Res. 2000;6(7):2585–97.
5. Tentori L, Graziani G. Recent approaches to improve the antitumor efficacy of temozolomide. Curr Med Chem. 2009;16(2):245–57.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献